Skip to content
10-Q

Quarterly Report

SKINOVATION PHARMACEUTICAL INCORPORATED

0001554795-22-000279

← back to feed
Filed
Aug 12, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 12, 2022 708K sh
Cash And Equivalents Q2 2022 · Jun 30, 2022 $82
Cash And Equivalents Q2 2022 · Dec 31, 2021 $222
Cash And Equivalents Q2 2022 · Jun 30, 2021 $1.85K
Cash And Equivalents Q2 2022 · Dec 31, 2020 $3.55K
Current Liabilities Q2 2022 · Jun 30, 2022 $395.9K
Current Liabilities Q2 2022 · Dec 31, 2021 $377.81K
Total Liabilities Q2 2022 · Jun 30, 2022 $395.9K
Total Liabilities Q2 2022 · Dec 31, 2021 $377.81K
Current Assets Q2 2022 · Jun 30, 2022 $82
Current Assets Q2 2022 · Dec 31, 2021 $222
Total Assets Q2 2022 · Jun 30, 2022 $82
Total Assets Q2 2022 · Dec 31, 2021 $222
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$5.2K
Stockholders Equity Q2 2022 · Jun 30, 2021 −$362.6K
Stockholders Equity Q2 2022 · Mar 31, 2021 −$355.15K
Stockholders Equity Q2 2022 · Dec 31, 2020 −$345.14K
Sga Expense Q2 2022 · Jun 30, 2021 $2.8K
Sga Expense Q2 2022 · Jun 30, 2021 $8.2K
Net Income Q2 2022 · Jun 30, 2021 −$7.45K
Net Income Q2 2022 · Jun 30, 2021 −$17.46K
Net Income Q2 2022 · Mar 31, 2021 −$10.01K
Operating Income Q2 2022 · Jun 30, 2021 −$2.8K
Operating Income Q2 2022 · Jun 30, 2021 −$8.2K